Skip to main content
Equibles

NewEdge Wealth, LLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1861796 STAMFORD, CT
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$89,633
-$2,744 QoQ
Shares Held
91,463
0.0% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 60 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NewEdge Wealth, LLC holds $28,019,722 across 22 Biotechnology names. TCRX ranks #21 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,305 $5,615,532
2 BHVN
Biohaven Ltd.
 245,670 $3,655,569
3 CORT
Corcept Therapeutics Inc
 34,890 $3,033,685
4 EXEL
Exelixis, Inc.
 51,642 $2,809,841
5 ALNY
Alnylam Pharmaceuticals, Inc.
 9,094 $2,737,566
6 INVA
Innoviva, Inc.
 99,367 $2,256,624
7 NVAX
Novavax Inc
 100,559 $947,265
8 VKTX
Viking Therapeutics, Inc.
 22,562 $880,143

All Filings in TCRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $89,633 91,463
2026-03-31 $92,377 91,463
2025-12-31 $91,463 91,463
2025-09-30 $166,462 91,463
2025-06-30 $132,621 91,463
2025-03-31 $126,218 91,463
2024-12-31 $278,047 91,463
2024-09-30 $455,485 91,463
2024-06-30 $535,058 91,463
2024-03-31 $726,216 91,463
2023-12-31 $533,229 91,463
2023-09-30 $234,145 91,463
2023-06-30 $228,657 91,463
2023-03-31 $192,072 91,463
2022-12-31 $141,767 91,463